Add BrightSurf on Google Email

Dieters decrease heart risk on moderate fat program

A moderate-fat diet, rich in monounsaturated fats from peanuts and peanut oil, produced a significant reduction in cardiovascular disease risk, with a 14% decrease compared to the low-fat group. The study found that despite weight loss, high fat diets can rebound and cause adverse effects on HDL cholesterol levels during maintenance.

SourcePenn State·JournalAmerican Journal of Clinical Nutrition·DateJan 29, 2004

Combined drug therapy prevents progression of prostate enlargement

Researchers found that a combined drug therapy of finasteride and doxazosin significantly reduced the risk of BPH progression by 66 percent, compared to placebo. The treatment also provided greater symptom relief and improved urinary flow rate. Men at highest risk for BPH progression, such as those with larger prostates or elevated ser...

Major advance in chemotherapy in breast cancer

The BCIRG 001 trial showed a significant reduction in recurrence of disease in hormone-receptor-positive and negative patients with a Taxotere-based treatment, improving disease-free survival by 28% and overall survival by 30%. The regimen demonstrated effectiveness across various stages of breast cancer.

Eating peanuts helps keep heart healthy without weight gain

Research by Richard Mattes and Corinna Alper found that regular peanut consumption reduces the risk of cardiovascular disease without causing significant weight gain. The study involved three trials where participants added peanuts to their diet, with no increase in body weight detected despite adding 500 calories a day.

SourcePurdue University·JournalJournal of the American College of Nutrition·DateJul 31, 2003

Other highlights of the July 16 JNCI

Research highlights the link between high animal fat intake and increased breast cancer risk, as well as the benefits of gynecologic surgeries in reducing ovarian cancer risk. Protein overexpression is also linked to esophageal cancer development, suggesting a potential target for prevention.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJul 15, 2003

Statins could reduce risk of cardiovascular disease

A new study found that statins can significantly reduce the risk of cardiovascular disease in people with high blood pressure and normal or low cholesterol levels. The treatment resulted in a 36% lower risk of primary events such as death from CHD and non-fatal heart attacks, primarily within the first year of treatment.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 2, 2003

Keeping tabs on teens may curb alcohol use and risks

A study of 444 managed-care patients aged 12-17 found that adolescents with consistently monitored parents were less likely to engage in alcohol-risk behaviors. The researchers suggest that monitoring may help reduce risk when adolescents are initially exposed to alcohol, but may be insufficient for high-risk behaviors.

SourceCenter for Advancing Health·JournalAmerican Journal of Health Behavior·DateFeb 24, 2003

Call for longer-term use of antidepressants

A meta-analysis of 31 trials involving over 4400 patients found that continuous antidepressant treatment for one to two years significantly reduced depressive relapse rates compared to placebo. The study suggests that many patients remain at risk of recurrence after initial treatment and may benefit from extended medication

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 20, 2003

Call for longer-term use of antidepressants

A study published in The Lancet found that treatment for one to two years with antidepressants substantially reduced the likelihood of relapse compared to discontinuing active treatment. The average rate of relapse on placebo was nearly double that of treatment, highlighting the benefits of long-term medication adherence.

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 20, 2003

Tamoxifen’s benefit greatest for preventing hormone-dependent breast cancer

A recent update of the Italian Randomized Trial of Tamoxifen found that tamoxifen significantly reduced breast cancer incidence by 82% in high-risk women. The study suggested that factors such as early menstruation, childlessness, and tall stature increase a woman's risk of developing ER+ breast cancer.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateJan 14, 2003